Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Prevention”

527 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 527 results

Not applicableStudy completedNCT00383500
What this trial is testing

Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status

Who this might be right for
LymphedemaBreast Cancer
Stanford University 75
Not applicableStudy completedNCT05408676
What this trial is testing

Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery

Who this might be right for
Mammary CancerPONV
Fudan University 198
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Not applicableLooking for participantsNCT06892093
What this trial is testing

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

Who this might be right for
HER2-positive Breast CancerDiarrhea Caused by DrugNeratinib
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 308
Early research (Phase 1)Study completedNCT00100893
What this trial is testing

IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 37
Large-scale testing (Phase 3)Study completedNCT00630695
What this trial is testing

Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer

Who this might be right for
Lymphocele
University Hospital, Limoges 148
Large-scale testing (Phase 3)Ended earlyNCT04395339
What this trial is testing

GM1 Prophylaxis for WBRT Related Cognitive Dysfunction

Who this might be right for
Brain MetastasesRadiotherapy Side EffectCognitive Impairment+2 more
Sun Yat-sen University 51
Not applicableStudy completedNCT06395896
What this trial is testing

The Effect of Breast Cancer Prevention Journey Program

Who this might be right for
Breast Cancer Female
Nurbanu Odacı 70
Not applicableStudy completedNCT06177795
What this trial is testing

Increasing Screening for Cancer Using EHR-Nudges

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 21,123
Not applicableStudy completedNCT00923377
What this trial is testing

Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 3
Not applicableNot Yet RecruitingNCT07722442
What this trial is testing

Personalised Behavioural Intervention in Cancer Screening Programmes

Who this might be right for
Dietary and Lifestyle Behaviour Change
Fundació d'investigació Sanitària de les Illes Balears 162
Testing effectiveness (Phase 2)UnknownNCT02447211
What this trial is testing

Topical Doxepin for Radiation-induced Dermatitis

Who this might be right for
Breast Cancer
Isfahan University of Medical Sciences 60
Large-scale testing (Phase 3)Study completedNCT03403712
What this trial is testing

Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Helsinn Healthcare SA 404
Not applicableLooking for participantsNCT07498829
What this trial is testing

Population Based Germline Testing for Early Detection and Prevention of Cancer

Who this might be right for
Breast Cancer RiskOvarian Cancer RiskCancer Gene Mutation
Queen Mary University of London 6,000
Not applicableLooking for participantsNCT07256119
What this trial is testing

Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients

Who this might be right for
Prevention
Ain Shams University 40
Not applicableStudy completedNCT03289364
What this trial is testing

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

Who this might be right for
Breast Cancer
Providence Health & Services 12
Testing effectiveness (Phase 2)Study completedNCT04637308
What this trial is testing

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

Who this might be right for
Fluid Retention
Guangdong Provincial People's Hospital 216
Post-approval studies (Phase 4)Ended earlyNCT00754767
What this trial is testing

L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityNeurotoxicity
HealthPartners Institute 2
Large-scale testing (Phase 3)Active Not RecruitingNCT02051218
What this trial is testing

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerBone Metastases
Swiss Cancer Institute 1,380
Testing effectiveness (Phase 2)Study completedNCT06033092
What this trial is testing

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

Who this might be right for
BRCA MutationPALB2 Gene MutationDuctal Carcinoma in Situ+6 more
European Institute of Oncology 110
Next Page